MedTrace Logo

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

NCT00963040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-06-15

Study results available
· View outcomes & findings →

Summary

The objective of this prospective, randomized, double-blind, parallel-group, placebo-controlled study is to determine the effectiveness of intranasal oxytocin in subjects suffering from chronic daily headache.

Conditions

  • Chronic Daily Headache

Interventions

DRUG

Syntocinon

4 actuations in each nostril for a total dose of 32 IU

DRUG

Sterile water

4 actuations in each nostril

DRUG

Syntocinon

8 actuations in each nostril for a total dose of 64 IU

DRUG

Sterile water

8 actuations in each nostril

Sponsors & Collaborators

  • MedVadis Research Corporation

    lead INDUSTRY

Principal Investigators

  • Egilius LH Spierings, MD, PhD · Harvard Medical School (HMS and HSDM)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00963040 on ClinicalTrials.gov